StreetAlpha.app
Home › Stocks › DNA

Ginkgo Bioworks Holdings, Inc. (DNA)

Healthcare
$8.32
▼ −2.06%
LAST CLOSE · NOV 17

Ginkgo Bioworks provides cell engineering research services and biosecurity monitoring services to government and commercial customers. It last closed at $8.32 on Nov 17, down 2.06% on the day. Over the past 90 days StreetAlpha recorded 1 whale options trade in DNA, 0% of them bullish and 100% bearish. In the past 30 days there were 2 dark pool prints totaling $819K, the largest $480K.

AI Auto Pilots
Is DNA in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$130.8M
−13.2% vs a year ago
Net income
−$251.0M
−192.0% margin
EPS (diluted)
−$4.17
Free cash flow
−$173.5M
−132.7% margin
Valuation
Market cap
$536.6M
64.5M shares
P/E
–
No P/E while losing money
Price to sales
4.1
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$84.5M
At Sep 30
Shareholder equity
$392.6M
Shares outstanding
64.5M
At Sep 30
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $313.8M$313.8MFY2021FY2022: $477.7M$477.7MFY2022FY2023: $251.5M$251.5MFY2023FY2024: $227.0M$227.0MFY2024FY2025: $170.2M$170.2MFY2025

From DNA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Hold
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Hold
1firm
0 Buy1 Hold0 Sell
Only 1 firm rated DNA in the past 90 days, not enough for a consensus
Average 12-month target
$11.00
▲ 32.2% upside

Based on 1 analyst who set a price target on DNA in the past 90 days. The average target is $11.00, with a high of $11.00 and a low of $11.00, compared with the last close of $8.32.

Low $11.00Avg $11.00High $11.00
Blue marker: last close $8.32
Highest target$11.00
Average target$11.00
Lowest target$11.00
Latest rating changes
TD CowenTarget raised
Oct 13Hold$9 → $11
TD CowenDowngrade
Aug 7Hold$9
DateFirmActionRatingPrice target
Oct 13TD CowenTarget raisedHold$9 → $11
Aug 7TD CowenDowngradeHold$9
Loading…

Technical Analysis

DNA · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend

The stock is 28% below its 20 day and 24% below its 50 day average. It is 4% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 40). The nearest support is the Pivot S1 at $8.06, and the nearest resistance the Pivot at $8.36.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 16.3%/day
Key levels
$18.2252 week high+119.0%
$10.6520 day average+28.0%
$10.3550 day average+24.4%
$9.65Swing high (Aug 5)+16.0%
$9.20100 day average+10.6%
$8.63200 day average+3.7%
$8.62Pivot R1+3.6%
$8.36Pivot+0.5%
$8.32Last close
$8.06Pivot S1−3.1%
$7.63Swing low (Jun 9)−8.3%
$5.3752 week low−35.5%
Indicators
RSI (14)40.00Middle of its rangeNeutral
MACD-0.34Below its signal lineBearish
Stochastic4.6Near the bottom of its rangeOversold
ADX (14)26.5Trending down
Williams %R-96.3Oversold below −80, overbought above −20Oversold
CCI (20)-153.5Oversold below −100, overbought above 100Oversold
Rate of change−22.7%Change over 10 sessionsBearish
ATR (14)$1.35Typical daily range, 16.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for DNA

What happened before

See how DNA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow DNA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How DNA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
1
Bullish
0
0%
Bearish
1
100%
Date span
Oct 27 – Oct 27
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
2
Notional
$819K
Largest print
$480K
Loading…

DNA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●89 buying vs 80 selling
  • ▲Held by funds +4.0 pts
  • ▼Funds holding -3
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding183186−1.6%
In funds' top 1023−33.3%
Held by funds60.1%56.1%+4.0 pts
New / increased30 / 5929 / 69−9.2%
Reduced / sold out48 / 3240 / 19+35.6%
Put/call ratio0.022.37−99.3%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See DNA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DNA is in one of them and how their past DNA trades turned out.

DNA in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered DNA in an article yet. Here's the latest on the wider market.

About Ginkgo Bioworks Holdings

Ginkgo Bioworks is a biotechnology company based in Boston, Massachusetts. It sells services to government and commercial customers in two areas. In cell engineering, it provides biological research services and lab tools to companies that develop medicines, vaccines, food, and industrial products. In biosecurity, it helps governments monitor and detect biological threats, using genomic data collected at sites such as airports and border checkpoints.

Headquarters
Boston, MA
Founded
2008